August 2008

Contract research helps keep drug pipeline flowing

August 18, 2008

Guest content from Turner Investment Partners‘ Heather Flick McMeekin, Frank Sustersic, Vijay Shankaran, and Theresa Hoang: Contract research helps keep drug pipeline flowing Imagine a new-product development process that typically lasts 10 to 15 years, has only a one in 5,000 chance of succeeding, and costs at least $800 million. That’s the daunting reality that [...]

Read the full article →

Building Biotechnology 3rd Edition now available

August 11, 2008

See larger image Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science (Paperback) By (author) Yali Friedman List Price: $64.95 USD New From: $54.99 In Stock Used from: $73.50 In Stock Building Biotechnology: Business, Regulations, Patents, Law, Politics, Science 460 pages Hardcover: 978-09734676-5-9 Softcover: 978-09734676-6-6 Third Edition August, 2008 Homepage The definitive primer and leading textbook [...]

Read the full article →

Beyond the Business Plan: Managing unexpected risk in biotechnology business development

August 6, 2008

Here’s a slideshow of a talk I recently gave at the Johns Hopkins biotechnology MS/MBA program. The purpose is to illustrate the elements which are important to consider after penning your business plan, and to help position oneself to be prepared for unexpected risks. The material is largely drawn from my book, Building Biotechnology. Go [...]

Read the full article →

Drug Patent Expirations in August 2008

August 1, 2008

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in August 2008 *Drugs may be covered by multiple patents Tradename Applicant Generic Name Patent Number Patent Expiration ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 4,992,474 Aug 12, 2008 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol xinafoate 5,126,375 Aug 12, 2008 ADVAIR DISKUS 100/50 Glaxosmithkline fluticasone propionate; salmeterol [...]

Read the full article →